NEW YORK (GenomeWeb News) – Fitch Ratings placed the ratings of Thermo Fisher Scientific and Life Technologies on Rating Watch Negative following Thermo Fisher's announcement on Monday that it plans to buy Life Tech for $13.6 million.

Thermo Fisher's ratings that were placed on Rating Watch Negative include the company's long-term issuer default rating, which is rated BBB+; short-term IDR, rated F2; senior notes, rated BBB+; and commercial paper, rated F2.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Differences in DNA methylation could be used to distinguish between DNA samples obtained from identical twins, researchers say.

A retrovirus that's been integrated into the human genome appears to have a role in embryonic development, researchers report.

A report from MIT identifies areas of scientific research where declining research support is hindering needed advances.

In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.